Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
02/2008
02/20/2008EP1889830A1 Biarylcarboxyarylamides as vanilloid-1 receptor modulators
02/20/2008EP1889829A1 Nonsteroic androgen acceptor regulators, preparation process, pharmaceutical composition and use thereof
02/20/2008EP1889828A1 Stable atomoxetine hydrochloride, a process for the preparation thereof, and an analytical control of its stability
02/20/2008EP1889639A2 Methods and compositions containing succinimide or maleimide derivatives of antineoplastic agents, for producing long lasting antineoplastic agents
02/20/2008EP1889633A1 Medicinal compositions for angiogenic therapy
02/20/2008EP1889632A1 Remedy for xanthoma
02/20/2008EP1889629A1 Stable formulation comprising a combination of a moisture sensitive drug and a second drug and manufacturing procedure thereof
02/20/2008EP1889626A1 Hip kinase for fertility control
02/20/2008EP1889625A1 Dietary supplement for supporting mental and physical performance
02/20/2008EP1889624A2 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives, taxanes and/or antimetabolites
02/20/2008EP1889623A2 Use of rhamnolipids in wound healing, treating burn shock, atherosclerosis, organ transplants, depression, schizophrenia and cosmetics
02/20/2008EP1889622A1 Spiropiperidine compound and medicinal use thereof
02/20/2008EP1889621A1 Multiparticulates
02/20/2008EP1889620A1 Eye drop containing roflumilast
02/20/2008EP1889619A1 Use of thiadiazolidine-derived compounds as neurogenic agents
02/20/2008EP1889618A1 Combined drug for treating diabetes
02/20/2008EP1889617A1 Triphenyl modified 5-membered heterocycles and their use as anticancer and antiflammatory agents
02/20/2008EP1889616A2 Extraction method of mixtures comprising ascorbic acid from a dry ground vegetable product
02/20/2008EP1889615A2 Formulations for oral administration with a health promoting effect on the osteoarticular and muscleskeleton apparatus
02/20/2008EP1889614A2 Methods of using rapid-onset selective serotonin reuptake inhibitors for treating sexual dysfunction
02/20/2008EP1889613A1 Pharmaceutical composition comprising vitamin k
02/20/2008EP1889612A2 Method for controlling micturition
02/20/2008EP1889611A1 Sugar-coated tablet
02/20/2008EP1889610A2 Bicalutamide compositions
02/20/2008EP1889609A2 Immune response modifier foam formulations
02/20/2008EP1889607A1 Injectable liquid paracetamol formulation
02/20/2008EP1889604A2 Use of a C-glycoside derivative to improve the barrier function of the skin
02/20/2008EP1889597A1 Active agent combinations of an ascorbyl compound and hydrogenated lecithin
02/20/2008EP1889582A2 Spine distraction implant and method
02/20/2008EP1889058A1 Diagnosis and treatment of endometriosis
02/20/2008EP1888782A2 Modulation of stat 6 expression for the treatment of airway hyperresponsiveness
02/20/2008EP1888771A2 Method for determining phytase activity
02/20/2008EP1888751A2 A hepatitis c virus non-structural ns3/4a fusion gene
02/20/2008EP1888749A1 Oligonucleotides for rna interference and biological applications thereof
02/20/2008EP1888728A1 Fatty acid analogues, i.e. dha derivatives for uses as a medicament
02/20/2008EP1888727A1 New dha derivatives and their use as medicaments
02/20/2008EP1888651A1 Aldehyde conjugated flavonoid preparations
02/20/2008EP1888624A2 Method of purifying apo-2 ligand/trail using crystallisation in the cold
02/20/2008EP1888616A1 Compounds useful for treating neurodegenerative disorders
02/20/2008EP1888615A1 17 -hsd1 and sts inhibitors
02/20/2008EP1888614A2 Process for preparing 3alpha(beta)-7alpha(beta)-dihydroxy-6alpha(beta)-alkyl-5beta-cholanic acid
02/20/2008EP1888597A2 Antibacterial agents
02/20/2008EP1888596A1 Substituted spiro compounds and their use for producing pain-relief medicaments
02/20/2008EP1888595A2 Spiro-oxindole compounds and their uses as therapeutic agents
02/20/2008EP1888594A2 Gabaergic agents to treat memory deficits
02/20/2008EP1888593A2 Thienopyridines
02/20/2008EP1888592A1 Spiroheterocyclic compounds and their uses as therapeutic agents
02/20/2008EP1888591A2 Derivatives of 6,7-dihydro-5h-imidazo[1,2-a]imidazole-3-sulfonic acid
02/20/2008EP1888590A2 Crystalline forms of a pyrrolotriazine compound
02/20/2008EP1888589A2 Pyrrolopyridine-based inhibitors of dipeptidyl peptidase iv and methods
02/20/2008EP1888588A2 Protein kinase inhibitors
02/20/2008EP1888587A1 2-amido-6-amino-8-oxopurine derivatives as toll-like receptor modulators for the treatment of cancer and viral infections, such as hepatitis c
02/20/2008EP1888586A2 2,3-substituted fused bicyclic pyrimidin-4(3h)-ones which modulate the function of the vanilloid-1 receptor (vr1)
02/20/2008EP1888585A1 Tetracyclic azapyrazinoindolines as 5-ht2 ligands
02/20/2008EP1888584A1 1, 6 -dihydro- 1,3, 5, 6-tetraaza-as-indacene based tricyclic compounds and pharmaceutical compositions comprising same as inhibitors of ikk enzyme activity
02/20/2008EP1888583A2 Hydantoin compounds
02/20/2008EP1888582A1 Imidazo- and triazolopyridines as inhibitors of 11-beta hydroxysteroid dehydrogenase type i
02/20/2008EP1888580A2 Pyrido[2,3-d]pyrimidines useful as hcv inhibitors, and methods for the preparation thereof
02/20/2008EP1888578A2 Imidazoquinolines as lipid kinase inhibitors
02/20/2008EP1888577A1 Ocaperidone salts and pharmaceutical compositions containing the same
02/20/2008EP1888575A2 Compounds for modulating trpv3 function
02/20/2008EP1888574A2 New antibiotic derivatives
02/20/2008EP1888573A1 Thiazole derivatives and use thereof
02/20/2008EP1888572A1 Quinazolines and their use as aurora kinase inhibitors
02/20/2008EP1888571A2 New salt and polymorphs of a dpp-iv inhibitor
02/20/2008EP1888569A1 Substituted piperidines as renin inhibitors
02/20/2008EP1888568A2 Substituted benzimidazole compounds with dual nos inhibitory activity and muopioid agonist activity
02/20/2008EP1888567A1 Heteroaryl-carboxylic acid (sulfamoyl alkyl) amide - derivatives as factor xa inhibitors
02/20/2008EP1888566A1 2-[(isoquinolin-3-carbonyl)amino]-propionic acid derivatives as inhibitors of factors xi and ix for the treatment of thrombosis
02/20/2008EP1888564A2 Benzofuran compounds
02/20/2008EP1888562A2 Dipeptidyl peptidase-iv inhibitors
02/20/2008EP1888561A1 Pyrazolyl-amino- substituted pyrimidines and their use in the treatment of cancer
02/20/2008EP1888559A2 Piperazine-piperidine antagonists and agonists of the 5-ht1a receptor
02/20/2008EP1888558A1 Bicyclic derivatives as modulators of ion channels
02/20/2008EP1888557A2 (5z)-5-(6-quinoxalinylmethylidene)-2-ý(2,4,6-trichlorophenyl)amino¨-1,3-thiazol-4(5h)-one
02/20/2008EP1888555A2 Substituted benzo-condensed cyclohexanone derivatives and the use thereof for medicament production
02/20/2008EP1888552A1 CRYSTALLINE FORM OF 1-CHLORO-4-(ß-D-GLUCOPYRANOS-1-YL)-2-[4-((S)-TETRAHYDROFURAN-3-YLOXY)-BENZYL]-BENZENE, A METHOD FOR ITS PREPARATION AND THE USE THEREOF FOR PREPARING MEDICAMENTS
02/20/2008EP1888551A1 Crystalline forms of 1-chloro-4-(beta-d-glucopyranos-1-yl)-2-[4-((r)-tetrahydrofuran-3-yloxy)-benzyl]-benzene, a method for its preparation and the use thereof for preparing medicaments
02/20/2008EP1888550A2 Apoptosis promoters
02/20/2008EP1888549A2 Biaryls useful as modulators of ion channels
02/20/2008EP1888548A1 Compositions and methods of treating retinal disease
02/20/2008EP1888547A1 Indane derivatives as modulators of ion channels
02/20/2008EP1888546A1 Thiazole derivatives and use thereof
02/20/2008EP1888543A1 Apoptosis promoters
02/20/2008EP1888542A1 Substituted spiro-compounds and the use thereof for producing medicaments
02/20/2008EP1888541A1 Benzo(d)isoxazol-3-yl-amine compounds and their use as vanilloid receptor ligands
02/20/2008EP1888538A1 (3,4-dihydro-quinazolin-2-yl)-(2-aryloxy-ethyl)-amines having an activity on the 5-ht receptor
02/20/2008EP1888534A2 Organic compounds
02/20/2008EP1888531A2 (5z)-5-(6-quinoxalinylmethylidene)-2-ý(2,6-dichlorophenyl)amino¨-1,3-thiazol-4(5h)-one
02/20/2008EP1888528A2 Phosphodiesterase 4 inhibitors
02/20/2008EP1888527A1 Piperidines for the treatment of chemokine mediated diseases
02/20/2008EP1888526A1 Piperidines for the treatment of chemokine mediated diseases
02/20/2008EP1888525A1 3,6-disubstituted azabicyclo [3.1.0]hexane derivatives as muscarinic receptor antagonists
02/20/2008EP1888524A1 Androgen modulators
02/20/2008EP1888519A2 Styrylsulfonamides, their manufacture and use as pharmaceutical agents
02/20/2008EP1888518A1 Novel 8-sulfonyl-3 aminosubstituted chroman or tetrahydronaphtalene derivatives modulating the 5ht6 receptor
02/20/2008EP1888517A1 Novel 8-sulfonylamino-3 aminosubstituted chroman or tetrahydronaphtalene derivatives modulating the 5ht6 receptor
02/20/2008EP1888514A1 Salts of substituted allophanates and their use in drugs
02/20/2008EP1888513A1 Novel trifluoromethoxy-substituted aryl anilides
02/20/2008EP1888512A2 Chemical compounds
1 ... 3373 3374 3375 3376 3377 3378 3379 3380 3381 3382 3383 3384 3385 3386 3387 3388 3389 3390 3391 3392 3393 ... 7860